These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 622047)

  • 1. Abnormal concentration and anomalous distribution of apolipoprotein A-I in Tangier disease.
    Henderson LO; Herbert PN; Fredrickson DS; Heinen RJ; Easterling JC
    Metabolism; 1978 Feb; 27(2):165-74. PubMed ID: 622047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma apolipoprotein concentrations in familial apolipoprotein A-I and A-II deficiency (Tangier disease).
    Alaupovic P; Schaefer EJ; McConathy WJ; Fesmire JD; Brewer HB
    Metabolism; 1981 Aug; 30(8):805-9. PubMed ID: 6790903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tangier disease. High density lipoprotein deficiency due to defective metabolism of an abnormal apolipoprotein A-i (ApoA-ITangier).
    Schaefer EJ; Kay LL; Zech LA; Brewer HB
    J Clin Invest; 1982 Nov; 70(5):934-45. PubMed ID: 7130397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of high density lipoprotein subfractions and constituents in Tangier disease following the infusion of high density lipoproteins.
    Schaefer EJ; Anderson DW; Zech LA; Lindgren FT; Bronzert TB; Rubalcaba EA; Brewer HB
    J Lipid Res; 1981 Feb; 22(2):217-28. PubMed ID: 6787156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of high-density lipoprotein apolipoproteins in Tangier disease.
    Schaefer EJ; Blum CB; Levy RI; Jenkins LL; Alaupovic P; Foster DM; Brewer HB
    N Engl J Med; 1978 Oct; 299(17):905-10. PubMed ID: 211412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subpopulations of high density lipoproteins in homozygous and heterozygous Tangier disease.
    Asztalos BF; Brousseau ME; McNamara JR; Horvath KV; Roheim PS; Schaefer EJ
    Atherosclerosis; 2001 May; 156(1):217-25. PubMed ID: 11369017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tangier disease: a structural defect in apolipoprotein A-I (apoA-I Tangier).
    Kay LL; Ronan R; Schaefer EJ; Brewer HB
    Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2485-9. PubMed ID: 6806810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the mechanism of hypertriglyceridemia in Tangier disease. Determination of plasma lipolytic activities, k1 values and apolipoprotein composition of the major lipoprotein density classes.
    Wang CS; Alaupovic P; Gregg RE; Brewer HB
    Biochim Biophys Acta; 1987 Jul; 920(1):9-19. PubMed ID: 3109493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma apolipoproteins in Tangier disease, as studied with two-dimensional electrophoresis.
    Visvikis S; Dumon MF; Steinmetz J; Manabe T; Galteau MM; Clerc M; Siest G
    Clin Chem; 1987 Jan; 33(1):120-2. PubMed ID: 3100093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro study of the pro-apolipoprotein A-I to apolipoprotein A-I converting activity between normal and Tangier plasma.
    Edelstein C; Gordon JI; Vergani CA; Catapano AL; Pietrini V; Scanu AM
    J Clin Invest; 1984 Sep; 74(3):1098-103. PubMed ID: 6432845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of lipoproteins and apolipoproteins in serum of a Tangier patient by micro-scale two-dimensional electrophoresis.
    Manabe T; Visvikis S; Dumon MF; Clerc M; Siest G
    Clin Chem; 1987 Apr; 33(4):468-72. PubMed ID: 3103952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, biochemical, and genetic features in familial disorders of high density lipoprotein deficiency.
    Schaefer EJ
    Arteriosclerosis; 1984; 4(4):303-22. PubMed ID: 6431953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restriction enzyme analysis of the apolipoprotein A-I gene in fish eye disease and Tangier disease.
    Rees A; Stocks J; Schoulders C; Carlson LA; Baralle FE; Galton DJ
    Acta Med Scand; 1984; 215(3):235-7. PubMed ID: 6428166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties of the plasma very low and low density lipoproteins in Tangier disease.
    Heinen RJ; Herbert PN; Fredrickson DS
    J Clin Invest; 1978 Jan; 61(1):120-32. PubMed ID: 201668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human proapoA-ITangier: isolation of proapoA-ITangier and amino acid sequence of the propeptide.
    Brewer HB; Fairwell T; Meng M; Kay L; Ronan R
    Biochem Biophys Res Commun; 1983 Jun; 113(3):934-40. PubMed ID: 6409109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tangier disease. In vitro conversion of proapo-A-ITangier to mature APO-A-ITangier.
    Bojanovski D; Gregg RE; Brewer HB
    J Biol Chem; 1984 May; 259(10):6049-51. PubMed ID: 6725246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The metabolic defect in Tangier Disease.
    Herbert PN
    N Engl J Med; 1979 Feb; 300(8):432-3. PubMed ID: 215911
    [No Abstract]   [Full Text] [Related]  

  • 18. Tangier disease with normal serum cholesterol.
    Frith RW; Hannan SF; Simcock JP; Scott PJ
    Aust N Z J Med; 1982 Oct; 12(5):515-9. PubMed ID: 6960872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High density lipoprotein infusion and partial plasma exchange in Tangier disease.
    Assmann G; Smootz E
    Eur J Clin Invest; 1978 Jun; 8(3):131-5. PubMed ID: 211037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary heart disease prevalence and other clinical features in familial high-density lipoprotein deficiency (Tangier disease).
    Schaefer EJ; Zech LA; Schwartz DE; Brewer HB
    Ann Intern Med; 1980 Aug; 93(2):261-6. PubMed ID: 7406376
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.